Navigation Links
5th Annual Global Conference on Stem Cell Therapy to be held Jan. 13-16, 2009 in NYC
Date:11/6/2008

WHAT: The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) is a three-day comprehensive program dedicated to the evolving field of cell-based therapies for treating cardiovascular diseases. The theme of this year's meeting is "Cellular and Molecular Building Blocks: Strategies for Cardiovascular Reconstruction in 2009."

WHY: Leaders in the field will convene to present basic, core discussions on stem cell science as well as their work, experiences, observations, and opinions on the benefits and drawbacks of the field. The 2009 meeting will encompass a broad range of cell-based therapeutic approaches to cardiovascular disease.

Research presented at IC3D will touch on topics such as:

  • Clinical studies of stem cell repair of the heart, brain and peripheral arteries
  • New sources of adult stem cells
  • Status of embryonic stem cell research
  • Molecular signaling and cellular responses
  • Models of acute and chronic myocardial injury
  • Methods for application of stem cell products
  • Engineered tissue including in vitro and in vivo studies
  • Imaging and other assessment methods

New sessions for 2009 will include:

  • Focus on peripheral vascular disease
  • An in-depth view of stem cell effects and how to best assess disease states
  • The convergence of cell and tissue modification as methods for enhancing the biologic effects of molecular and cellular agents

WHO: Warren Sherman, M.D., Conference Director, is Director of Cardiac Cell-Based Endovascular Therapies at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital and Columbia University Medical Center. Dr. Sherman is a renowned clinical investigator in the field of myocardial regeneration who pioneered a technique for injecting stem cells into the heart. In Rotterdam in May 2001, he performed the first catheter-based injection of stem cells into the heart of a patient with congestive heart failure due to a previous heart attack. At Columbia University Medical Center, researchers led by Dr. Sherman are using the patient's own myoblasts -- progenitor cells found in muscle -- to repair and replace injured cardiac tissue in a process called myogenesis. Dr. Sherman collaborates in studies to improve the outcomes of cell implantation with colleagues at Columbia University Medical Center, all of whom will be presenting their research at the conference.

WHEN: January 13 16, 2008

WHERE: The New York Academy of Medicine, New York, NY


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
2. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
3. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
4. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
5. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
6. Annual flu shot cuts need for doctors visits, hospitalization among children
7. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
8. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
9. Chem Rx to Present at Bear Stearns 20th Annual Healthcare Conference
10. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
11. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... 2017 , ... Preora Diagnostics Inc. , a privately ... received two prestigious recognitions that acknowledge the promise of its PWS Nanoctyology platform ... been named a Top 100 Finalist for the 16th annual Chicago Innovation Awards ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that specializes ... to the athletic wear market with the launch of their FlipBelt Crops. , The ... essentials securely at their fingertips while at the gym, on the trail, or on-the-go. ...
(Date:9/21/2017)... CO (PRWEB) , ... September 21, 2017 , ... ... Interview of the Month, Lewis and Clark College Emeritus Professor of Education Gregory ... Faith Boninger, co-author of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and ...
(Date:9/20/2017)... Virginia (PRWEB) , ... September 20, 2017 , ... ... Flex Pure Clinical Plus Coating System for clients that rely on safety and ... the growth of microorganisms. , Silver has been used for centuries for its ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... Doctors on ... to their qualified network of medical professionals working on a personal injury lien basis. ... Spine Surgery Inc brings these esteemed doctors’ vast experience with orthopedic injuries to patients ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... N.Y. , Sept. 6, 2017   PDI , ... announced it will host an educational session focused on ... bloodstream infection (CLABSI) prevention at the 2017 Annual Scientific ... which will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/6/2017)... 6, 2017 Eli Lilly and Company (NYSE: ... new data for galcanezumab and lasmiditan, two investigational treatments ... Headache Society (IHC) taking place Sept. 7-10 in ... highlight new, long-term data from an open-label study evaluating ... (120 mg and 240 mg) for the prevention of ...
Breaking Medicine Technology: